“…Typically, the therapy is used for conditions, such as Parkinson's disease and dystonia (Krauss et al, 1999;Starr et al, 2004;Rodriguez-Oroz et al, 2005;Bronstein et al, 2011), yet recently it has also been tried experimentally for treating BG-mediated hyperkinetic motor disorders, such as motor tics and Tourette syndrome (TS) (Vandewalle et al, 1999;van der Linden et al, 2002;Houeto et al, 2005;Shahed et al, 2007;Dehning et al, 2008;Dueck et al, 2009;MartinezTorres et al, 2009;Welter et al, 2010;Azoulay-Zyss et al, 2011;Martinez-Fernandez et al, 2011;Piedimonte et al, 2012). The emerging clinical data with respect to HF-DBS for TS is also supported by positive responses to stimulation in animal models of tourettism McCairn et al, 2012).…”